Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer
Article first published online: 18 FEB 2014
© 2014 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Volume 105, Issue 3, pages 272–280, March 2014
How to Cite
Cancer Sci 105 (2014) 272–280
Japan Society for the Promotion of Science.
- Issue published online: 6 MAR 2014
- Article first published online: 18 FEB 2014
- Accepted manuscript online: 17 JAN 2014 10:15AM EST
- Manuscript Accepted: 13 JAN 2014
- Manuscript Received: 6 NOV 2013
- Manuscript Revised: 9 JAN 2013
- Japan Society for the Promotion of Science (Kakenhi). Grant Number: 24390303
|cas12354-sup-0001-FigS1.jpg||image/jpg||223K||Fig. S1. Knockdown efficacy of Smoothened (Smo) siRNA in GBd15 and TGBC2TKB gallbladder cancer cells.|
|cas12354-sup-0002-FigS2.jpg||image/jpg||250K||Fig. S2. Knockdown efficacy of MMP-2 and MMP-9-siRNA in GBd15 and TGBC2TKB gallbladder cancer cells.|
|cas12354-sup-0003-FigS3.jpg||image/jpg||255K||Fig. S3. Transfection with MMP-2 and MMP-9 siRNA does not affect proliferation in GBd15 and TGBC2TKB gallbladder cancer cells.|
|cas12354-sup-0004-TableS1.docx||Word document||54K||Table S1. Polymerase chain reaction primer sequences.|
|cas12354-sup-0005-TableS2.docx||Word document||37K||Table S2. Clinical background of the samples used for immunohistochemistry.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.